GOLDBUG STRATEGIES LLC for GENOMIC HEALTH INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 19, 2012 | $30,000 | Replaced |
| 2nd Quarter - Report (this page) | Jul 19, 2012 | $30,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHEILA D WALCOFF | Committee, US House Of Representatives |
Medicare/Medicaid MMM
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHEILA D WALCOFF | Committee, US House Of Representatives |
Medical/Disease Research/Clinical Labs MED
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHEILA D WALCOFF | Committee, US House Of Representatives |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.